Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose vs Standard-dose Ticagrelor in Chinese ACS Patients Undergoing PCI
NCT03381755Phase 4Unknown
- Sponsor
- The First Affiliated Hospital of Harbin Medical University
- Start
- Jan 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ticagrelor in acute coronary syndrome (ACS) (2 arms), sponsored by The First Affiliated Hospital of Harbin Medical University. Primary endpoint: Thromboelastogram at 1 year. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT03381755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03381755.